Focus Partners Advisor Solutions
RDY icon

Focus Partners Advisor Solutions’s Dr. Reddy's Laboratories RDY Stock Holding History

Focus Partners Advisor Solutions’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-13,190
Closed -$193K – 1484
2026
Q2 		$193K Buy
13,190
+687
+5% +$9.27K ﹤0.01% 1178
2026
Q1 		$173K Sell
12,503
-165
-1% -$2.3K ﹤0.01% 1173
2025
Q4 		$178K Sell
12,668
-367
-3% -$5.15K ﹤0.01% 1038
2025
Q3 		$176K Buy
+13,035
New +$188K ﹤0.01% 1080

Other funds holding RDY

Aikya Investment Management
Aikya Investment Management London, United Kingdom $337M AUM 15.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return
Arrowpoint Investment Partners
Arrowpoint Investment Partners Singapore $2.31B AUM 65.02% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
B. Metzler seel. Sohn & Co
B. Metzler seel. Sohn & Co Frankfurt, Germany $11.5B AUM 29.17% 1-Year Est. Return

Focus Partners Advisor Solutions's RDY Position: Q3 2026 in Review

Focus Partners Advisor Solutions sold out of Dr. Reddy's Laboratories (RDY) in Q3 2026, closing a stake of 13,190 shares — an estimated $193K sold.

Focus Partners Advisor Solutions first reported a position in RDY in Q3 2025 and held it in 4 quarters. The position peaked at $193K in Q2 2026. 132 funds tracked by Wall St. Rank hold RDY as of Q3 2026.

  • Focus Partners Advisor Solutions reported no remaining Dr. Reddy's Laboratories position as of Q3 2026 after selling out during the quarter.
  • Focus Partners Advisor Solutions sold 13,190 Dr. Reddy's Laboratories shares in Q3 2026, an estimated $193K.
  • Focus Partners Advisor Solutions first reported a position in Dr. Reddy's Laboratories in Q3 2025 and held it in 4 quarters.
  • Focus Partners Advisor Solutions's Dr. Reddy's Laboratories position peaked at $193K in Q2 2026.
  • 132 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q3 2026, filed 10 Nov 2026.